B. Braun and Health-Robotics announced a long-term and exclusive strategic agreement for B. Braun to exclusively utilize Health-Robotics' IV Admixture Automation Solutions worldwide within the Oncology, Pain Management, Antibiotics, Radio Pharmaca, and all other IV Therapy and Clinical Nutrition. In addition, B. Braun has immediately acquired from Health-Robotics the long-term, exclusive rights to manufacture, assemble, market, license, provide installation and integration services and support for the CytoCare Robot in Europe, Latin America, Africa, Oceania, and most of Asia.
With its CytoCare Robot, Health-Robotics has developed the first totally automated system for safe preparation of patient-specific hazardous IV doses. "CytoCare constitutes a breakthrough advance for patient and clinician's safety," says Werner Rainer, General Manager, Health-Robotics. "This strategic agreement with B. Braun combines state-of-the-art technologies to achieve the accuracy and sterility that providers require for automating patient-specific IV admixture preparations with B. Brauns world-class organization. The resulting technology is the only totally automated system for handling hazardous IV admixtures available in the market. In addition, CytoCare is the only IV Admixtures Preparation Automated solution that enables global health care providers with flexibility to utilize a wide range of final IV containers", he adds. "Everyone within our company and customer base is extremely proud of being selected by an organization of the caliber and outstanding reputation of B. Braun."
This agreement tightly fits with B. Braun's mission of becoming customer's first choice for infusion therapy and providing world-class technology for IV pharmacy operations. Markus Strotmann, Senior Vice President of Strategic Marketing for B. Braun Melsungen AG notes, "B. Braun is very pleased to reach a long-term strategic agreement with Health-Robotics. We have closely worked with Health-Robotics for approximately one year market-testing the concept of CytoCare and conducting technical due diligence. We hope that this strategic collaboration with Health-Robotics grows over time in delivering improved patient safety solutions to B. Braun's customers in areas beyond Oncology and to continue the integration work we initiated last year with our industry-leading Ecoflac and EasyPump solutions. Such an end-to-end solution for IV Therapy will also help drive down the complexity, medication errors, initial cost and daily operating expenses - which are key issues for healthcare organizations."
About B. Braun Melsungen AG
B. Braun supplies the global healthcare market with products for anesthesia, intensive medicine, cardiology, extra corporeal blood treatment and surgery, as well as services for hospitals, general practitioners and the homecare sector. Through dialogue with those who are using B. Braun's products on a daily basis, the company is continually gaining new knowledge, which it incorporates into product development. In this way, the company contributes with innovative products and services towards optimizing working procedures in hospitals and medical practices all over the world and improving safety for patients, doctors and nursing staff. For more information, please visit http://www.bbraun.com.
About Health Robotics GmbH
Health Robotics is the leading global supplier in the automation of life-critical intravenous patient-specific medication preparation, especially chemotherapy. Its mission is to provide healthcare facilities with automated solutions that ease pharmacies growing pressures by improving patient safety, reducing life-threatening medication errors and contamination risks, working more efficiently, increasing throughput, and containing spiraling chemotherapy expenses. For more information, please visit http://www.health-robotics.com.